Tag Archives: CQC

Cannabis Won Big: A Post-Election Analysis

Editor’s Note: This article has been updated to include the presidential and congressional election results.


While the votes continue to come in for the presidential and congressional elections and we have some concrete results materializing, cannabis legalization has emerged as a clear winner across the board. Five states had initiatives on the ballot to legalize cannabis in one form or another and voters in all five states approved those measures by wide margins.

As of this writing, 15 states now have legalized adult use cannabis and 36 states have legalized medical cannabis. That is a significant portion of the United States with some form of legal cannabis, even without counting the emergent hemp markets across the country.

After a tight race and mail-in vote counts diminishing President Trump’s lead days following the election, Joe Biden has won the White House. Most cannabis industry stakeholders see this as a win for cannabis as both Biden and Vice President-Elect Kamala Harris have voiced support for federal decriminalization of cannabis. The vocal support is very much so tied to their campaign on ending racial injustices and systemic racism, citing the failed war on drugs for disproportionately harming communities of color.

While it is looking like the Democrats will retain control of the House of Representatives, it is still unclear which party will control the Senate. That  question likely won’t be answered until January 2021, when voters in Georgia will decide on two Senate seats in runoff elections that will decide which party gets the majority. With a Democratic majority in the House and Senate, it is entirely possible that the Biden administration could decriminalize cannabis on a federal level within the next four years. Without that majority, however, it is possible reform could come at a much slower pace.

As more states legalize cannabis, their neighbors see the potential economic benefits and want to cash in on the movement. Just take a look at the West Coast.

Comments made by politicians leading up to the election in the Northeast also shed some light on the alleged domino effect coming to the United States. In late October, about two weeks before the election, New York Governor Andrew Cuomo was asked when his state will legalize adult use cannabis. His answer: “Soon, because now we need the money.” Back in September, Pennsylvania Governor Tom wolf specifically asked the state legislature to legalize adult use cannabis. Governor Wolf said “people will go to New Jersey” to purchase cannabis once it becomes legal in the neighboring state.

Question 1 in NJ won by a very wide margin

Well, New Jersey legalized adult use cannabis. So now it appears we are in a waiting game to see which neighboring state will move forward before the other. Alyssa Jank, consulting services manager at Brightfield Group, predicts cannabis sales in New Jersey to reach about $460 million in 2021, up from about $94 million this year. She says the market could reach $1.5 billion by 2025.

Sam D’Arcangelo, director of the Cannabis Voter Project, a division of HeadCount, says the New Jersey measure is pretty bare-bones, so the legislature will need to pass enabling legislation that actually creates the adult-use program. “It’s tough to tell exactly what that legislation will look like or how long it will take to pass, but it’s possible it will be approved pretty quickly,” says D’Arcangelo. “Tonight’s results could set off a domino effect that inspires lawmakers to move forward with legalization in a number of states throughout the region.”

Let’s take a closer look at Arizona: Back in 2016, Arizona had a measure on the ballot to legalize adult use cannabis that failed to get enough votes. Things have clearly changed in the state in the last four years because Prop. 207 (the 2020 ballot initiative to legalize adult use cannabis) won 59.8% to 40.2%. Arizona now joins a massive West Coast bloc of states slowly creeping inland that have legalized adult use cannabis, including, Washington, Oregon, California, Nevada and now Arizona, not to mention Montana. Drug Policy Alliance’s Emily Kaltenbach believes that New Mexico will follow suit as well, with three out of four voters in the state in favor of it.

Voters in Mississippi approved a medical cannabis program by a wide margin with almost 74% in favor. Even more encouraging, voters in the state rejected the legislature’s attempt to hijack the initiative with their own alternative measure that would have involved developing their own program as they see fit without any sort of deadline.

While Montana can tend to lean slightly Democrat, it is surrounded by heavily Republican-dominated states like Wyoming and Idaho. With both Montana and South Dakota voters approving adult use legalization measures, this presents a potential inroad for cannabis to reach far more conservative states in the Northern Rockies and beyond.

Greg Kaufman Partner at Eversheds Sutherland and frequent Cannabis Industry Journal contributor, says this election puts considerable pressure on Congress to take some action on one or more of the cannabis-related bills currently pending. “In several states, cannabis was more popular than the winning presidential candidate, regardless of the party of the winning candidate,” says Kaufman. “This suggests that cannabis is not a partisan issue, nor should it be.”

The 15 states that have legal adult use cannabis now represents about 34% of the population in our country. “During the most divisive election in modern U.S. history, Americans demonstrated unity around at least one issue – cannabis policy reform,” says Aaron Smith, co-founder and chief executive officer of the National Cannabis Industry Association. He says the victories we saw this week are commendable and will lead to a lot of new jobs, tax revenue and thousands of fewer arrests, but there is still a lot of work to be done. “We look forward to building on this progress as we continue to work with Congress to end the conflict between outdated federal laws and the growing number of states with regulated cannabis markets, and help undo the racially and economically disparate harms caused by prohibition.”

While we wait to hear who will control the Senate in 2021, which will have a massive impact on cannabis reform, we leave you with this great quote from Aaron Smith: “There is still a lot of work to do, but the wind is at our backs.”

To see the details and results of each cannabis measure on the ballot in this election, click here. 

Cannabis Sweeps: AZ, MS, MT, NJ & SD Approve Legalization

Five states had cannabis reform on the ballot yesterday for the 2020 election: Arizona, Mississippi, Montana, New Jersey and South Dakota. All five ballot initiatives won by a clear margin, with some races ending in landslides. Stay tuned for coverage on congressional and presidential elections and the impact on the future of the cannabis industry.

For now, here are which states legalized cannabis last night, as well as some details on the five (well, technically eight) state ballot initiatives:

Arizona – Prop. 207 (Adult Use)

Results: 59.8% Yes, 40.2% No

Details:

  • Legalizes cannabis for adults over 21
  • Puts a 16% tax on retail sales of cannabis and cannabis products
  • Develops a process for expunging records of cannabis-related drug offenses
  • Arizona already has an established medical cannabis program

Mississippi – Initiative Measure 65 & Alternative Measure 65A (Medical)

Results: 67.9% Yes for either, 32.1% No against both

Details:

  • Both initiatives theoretically legalize medical cannabis in the state.
  • There is a legislature-proposed alternative on the ballot, which makes things a bit confusing and gives voters the option of voting for both, neither or one of the two.
  • Initiative 65 would give the state’s department of health a mandate and authority to establish regulations for a medical cannabis program by August 2021. This initiative lists 22 qualifying conditions.
  • Initiative 65A gives the legislature the power to come up with their own program as they see fit and does not include any sort of deadline.

Montana – Initiative 190 (Adult Use) & Initiative 118

Results: 56.6% Yes, 43.4% No

Details:

  • Legalizes, taxes and regulates cannabis for adults over 21
  • Requires the state’s department of revenue to license and regulate cannabis businesses
  • Puts a 20% tax on retail sales of cannabis and cannabis products
  • Develops a process for expunging records of cannabis-related drug offenses
  • Montana already has an established medical cannabis program

Initiative 118:

  • This just allows the language of the initiative to call an adult over 21, instead of 18 as it is stated in the Montana constitution. 

New Jersey – Question 1 (Adult Use)

Results: 66.9% Yes, 33.1% No

Details:

  • Legalizes, taxes and regulates cannabis for adults over 21
  • New Jersey already has an established medical cannabis program – this ballot measure gives authority to the regulatory body currently overseeing the medical program, the five-member Cannabis Regulatory Commission.
  • Only applies the 6.625% state sales tax and prohibits additional sales taxes.
  • This made it to the ballot by way of legislature after New Jersey lawmakers failed to pass it in 2019, instead passing the question on to voters. New Jersey does not have a ballot initiative process.

South Dakota – Constitutional Amendment A & Initiated Measure 26 (Adult Use & Medical)

Details:

Constitutional Amendment A Results: 53.4% Yes, 46.6% No

  • Legalizes, taxes and regulates cannabis for adults over 21
  • This also requires the state legislature to set up a medical program as well as a hemp program by April 2022.
  • Puts a 15% tax on retail sales of cannabis and cannabis products
  • Gives local governments authority to allow or ban cannabis businesses

Initiated Measure 26 Results: 69.2% Yes, 30.8% No

  • Establishes a medical cannabis program in South Dakota
  • It does list a few qualifying conditions like severe nausea, chronic pain, seizures and more, but it gives the state’s department of health the power to add more conditions to that list.
  • SD Department of health would have 120 days to set up regulatory framework.

2020 CQC Episode 9, Safety, Quality & Compliance

By Cannabis Industry Journal Staff
No Comments

2020 Cannabis Quality Virtual Conference

Safety, Quality & Compliance (Episode 9)

Preparing for Federal Legalization: FDA Compliance for the Cannabis Industry

  • Kim Stuck with Allay Consulting

She will cover important FDA/food safety practices, issues they ran into when cannabis was first regulated by a public health authority, things different from other wholesale food operations, tips on how to stay compliant and much more.

Establishing Cannabis Quality and Safety Attributes

  • Josh Wurzer with SC Labs

He will discuss the ideal parameters for cannabis quality assurance testing. Wurzer will also shed some light on the work the industry is conducting to establish standards around quality, testing, efficacy and consumer protection.

Click here to watch the recording 

2020 CQC Episode 8, Supply Chain Quality

By Cannabis Industry Journal Staff
No Comments

2020 Cannabis Quality Virtual Conference

Safety, Quality & Compliance (Episode 8)

Upstream Innovations in Mold Mitigation

  • Bernie Lorenz, Ph.D with ProKure Solutions

He will outline upstream approaches to help growers minimize harmful microorganisms and maximize crop production as a result.

Tech Talk: Is it Time to Step Up to a Cloud ERP System?

  • Tom Brennan with Rootstock Software

He will detail how cannabis producers can improve their operations with an end-to-end cloud platform that provides data integration across an organization’s operation.

Practical Analytical Considerations for Cannabis Producers & Processors

  • Taylor Trah with OutCo

He will discuss where testing fits into a vertically integrated operation, the different analytical devices that might be required and in depth considerations to make certain in-house analytics are right for your operation.

Click here to watch the recording

2020 CQC Episode 7, The East Coast Market Update

By Cannabis Industry Journal Staff
No Comments

2020 Cannabis Quality Virtual Conference

Safety, Quality & Compliance (Episode 7)

A Progress Update: Tracking the Markets in the Northeast

  • Steve Schain with the Hoban Law Group

He will take a close look at markets in states like NJ, PA, NY, CT, DE and MA, among others. He’ll look into how each market is developing, which ones might have more red tape than others and what the future might hold for the East Coast market.

The East Coast Model: How Regulations Are Defining the Mid-Atlantic

  • Joel Chapelle with Food Industry Counsel

He will discuss the regulations in states along the Eastern seaboard and go in-depth on how a lot of Eastern states have adopted regulations that differ greatly from the traditional West Coast model.

Click here to watch the recording 

2020 CQC Episode 6, Lab Testing

By Cannabis Industry Journal Staff
No Comments

2020 Cannabis Quality Virtual Conference

Lab Testing (Episode 6)

Top Ten Deficiencies Found During Cannabis Laboratory Assessments

  • Anna Williams, A2LA

This presentation will go through the top ten deficiencies that A2LA has found during their assessments of cannabis laboratories. We will touch on each area of noncompliance and provide common reasons why laboratories have been found to be non-compliant with certain areas of ISO/IEC 17025:2017.

Tech Talk: The Future of Microbial Testing in Cannabis – PathogenDX

  • Dr. Ben Katchman, PathogenDx

Method Validation for Cannabis Testing

  • Jason Stine, ANAB
Method validation plays an integral role in planning for quality results in any testing laboratory. Validation should include a systematic assessment of factors influencing results, inter-laboratory comparisons, and testing method robustness through variation of controlled parameters. In the absence of industry standard methods for cannabis testing, robust and rigorous method validation is critical to ensure the test methods are fit for the intended use. Method validation must be a planned activity in the laboratory.
Tech Talk: Beyond Analytical Solutions – Phenomenex
  • Sean Orlowicz, Phenomenex

Click here to watch the recording

Vermont Legalizes Cannabis

On Tuesday, September 22, the Vermont Senate voted (23-6) to pass a bill that would legalize, tax and regulate adult use cannabis sales. The bill, S. 54, was approved by 92-56 in the Vermont House of Representatives earlier in the month.

Vermont Gov. Phil Scott

Governor Phil Scott did not sign the bill, but let it become law anyway without his signature late Wednesday night on October 7. He did however sign separate legislation that will expunge previous cannabis-related convictions.

With this piece of legislation becoming law, Vermont  is now the 11th state to regulate and tax cannabis sales. The Marijuana Policy Project has a helpful summary of the legislation you can find here.

Back in 2018, Vermont actually voted to legalize adult use possession and cultivation of cannabis, just not to tax and regulate it. Governor Scott signed that bill into law a couple years ago.

Previously, Vermont and Washington D.C. had legislation that legalized cannabis, just not the sale of it. Technically speaking, it is still illegal to sell cannabis in D.C.

2020 CQC Episode 5, HACCP & GMPs

By Cannabis Industry Journal Staff
No Comments

2020 Cannabis Quality Virtual Conference

HACCP & GMPs (Episode 5)

Risk Characterization: A key component to develop HACCP Plans

  • Radojka Barycki, SCS Global Services

One of the key steps in the development of a HACCP Plan is Hazard Analysis. Hazard analysis requires the risk characterization. Risk characterization has two main components: 1) hazard identification; and 2) hazard characterization. I have evaluated several HACCP Plans through my professional career and have found that risk characterization is a step that is not done properly frequently. This presentation addresses the components of risk characterization and presents a practical example to complete this important area in the development of a HACCP Plan.

Good Manufacturing Practices (GMPs) and Cannabis

  • Tara Couch, EAS Consulting Group

As States begin to legalize and regulate the Cannabis industry, important considerations must be addressed. One of these is the development and implementation of Good Manufacturing Practices (GMPs) and a quality system that meets the new state regulations. While not all state regulations are the same, some are similar to the food industry and others more like dietary supplement and pharmaceutical GMPs, the expectation across the board is that facilities throughout the supply chain will have these systems and be closely monitored. Learn the basic tenants of any GMP and quality system and how implementing a GMP system is your facility will not only ensure compliance but also streamline your business.

Click here to watch the recording

2020 CQC Episode 4, Licensing Applications

By Cannabis Industry Journal Staff
No Comments

2020 Cannabis Quality Virtual Conference

Licensing Applications (Episode 4)

Property and People and Paperwork, Oh My! License Application Prep For Success

  • Victoria Trusty and Greg Huffaker, Canna Advisors

Attendees will learn from industry veterans who have helped clients win licenses across the US. 1. Get tips on property selection details and timing 2. Understand social equity opportunities and requirements 3. How and when to build out your team 4. Gain practical insights that only come with working on applications in multiple states.

Show Me Medical Cannabis! Case studies in Missouri clients’ wins and woes

  • Victoria Trusty and Greg Huffaker, Canna Advisors

Attendees will learn how to avoid common pitfalls from a case study analysis of the Missouri application process. What helped applicants win? What caused applicants to lose points? How do attendees apply these learnings to their own application? 1. Learn the basics of the application process 2. How to plan for success 3. Learn how to avoid property woes, with real world examples 4. Gain insights on building your team to maximize points 5. Learn about key phases where funding is critical and allocating funds for the most impact 6. Understand how project and time management can be your “secret sauce.”

Click here to watch the recording

2020 CQC Episode 3, Standards, Quality & Sustainability

By Cannabis Industry Journal Staff
No Comments

2020 Cannabis Quality Virtual Conference

Standards, Quality & Sustainability (Episode 3)

What’s In My Weed? A Panel on Cultivation

  • Rudy Ellenbogen, Whole Grow
  • Amy Lee Andrle, L’Eagle Services
  • Daniel Banks, LightShade
  • Ben Gelt, CCC
  • Karyemaitre Aliffe, Ethicannos

Ben Gelt, Board Chair of the CCC, will moderate a panel of leading cannabis and cannabis products producers to discuss supply chain, production and other difficulties in creating cannabis products and the challenges inherent in teaching consumers to be more discerning.

What’s in my Weed? A Panel on Derivative Goods
  • Jim Makoso, Lucid Lab group
  • Austin Stevenson, Vertosa
  • Ben Gelt CCC

Ben Gelt, Board Chair of the CCC, will moderate a panel of leading cannabis and cannabis products producers to discuss supply chain, production and other difficulties in creating cannabis products and the challenges inherent in teaching consumers to be more discerning.